RITSUKO KOMAKI to Receptors, Tumor Necrosis Factor, Type II
This is a "connection" page, showing publications RITSUKO KOMAKI has written about Receptors, Tumor Necrosis Factor, Type II.
Connection Strength
0.098
-
TNFRSF1B +676 T>G polymorphism predicts survival of non-small cell lung cancer patients treated with chemoradiotherapy. BMC Cancer. 2011 Oct 14; 11:447.
Score: 0.098